FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Postoperative Dental Pain
• Rheumatoid Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)